Challenging the dry eye paradigm: Technicians measure things, clinicians do what's important - Thea Pharmaceuticals

This session is now fully booked

About the session

CPD ref: C-108354 


This session will critique the TFSO DEWS II mantra, with your support and input; as peers and perhaps future Key Opinion Leaders (KOLs), we should always question and challenge what we do. 

The session will concentrate on the two primary DEWS II flow diagrams to discuss concepts which, as a clinician rather than an academic, could be problematic. So we will look to answer a number of questions including: 

  • Is ‘dry eye disease’ really a suitable moniker for what we deal with – is it an outcome or a disease?
  • Importance of non-invasive tests?
  • What is a ‘Lacrimal Functional Unit’ and should it be incorporated in a workable definition?
  • What do you do if you have access to only a limited number of the homeostasis marker tests and these show negative results?
  • Can an exhaustive work-up really be compartmentalized into a set of triaging questions, a minimal list of generic risk factors and three homeostatic markers?
  • How serious are we about medication litanies and systemic health?

The last part will be the focus of a breakout discussion for delegates to consider in more detail.

Domains and learning outcomes

Clinical practice

  • Be able to reflect on your practice and seek to improve the quality of your work with patients that have ocular surface disease by appraising research and guidelines such as the TFOS DEWS II report, understanding the condition presenting to you, and implementing actions from these in care provided to patients (Standard 5.4)
  • Understand how to conduct an adequate assessment for patients presenting with ocular surface symptoms, including where necessary any relevant medical, family, and social history of the patient, leading to an appropriate diagnosis and management plan (Standard 7.1).


Dr Peter Frampton DOptom MSc FCOptom BAppSc(Optom)(AUS) DipTp(AS) DipTp(SP) DipTp(IP)

Peter Frampton trained as an optometrist at QUT, Brisbane Australia; he moved to Britain in 1986 and took ownership of Aaron Optometrists in 1993. A Masters Degree with Distinction in Ocular Therapeutics was attained from Bradford University. 

In 2009 Peter achieved Additional Supply and Supplementary Prescribing status and was one of the first 30 optometrists to pass the Independent Prescriber common assessment in the same year. In 2011 he was made a Fellow of The College of Optometrists for recognition of his ‘commitment to clinical excellence’. Peter successfully achieved his Doctorate via Aston University is 2017. Peter is a visiting lecturer for Independent Prescribing at the University of Hertfordshire.